GI Effects Dysbiosis Score Test · Stool

Your gut hosts trillions of bacteria, and the balance among them shapes digestion, immunity, and inflammation throughout your body. When that mix shifts toward patterns seen in inflammatory bowel disease (a group of chronic gut inflammation conditions including Crohn's and ulcerative colitis) or irritable bowel syndrome (a common condition causing abdominal pain and altered bowel habits), that shift is called dysbiosis.

This score condenses your gut microbial picture into a single number by comparing your sample against reference patterns. It is a research-driven, exploratory measure rather than a stand-alone diagnostic test, but it can give you an early signal about whether your gut ecosystem looks more like that of healthy people or more like those with active gut disease.

What This Score Actually Captures

The score reflects the composition of bacteria in your stool, comparing the abundance of different species against a reference of healthy individuals. Microbiome-based dysbiosis indexes typically use a log ratio of bacteria associated with disease versus bacteria associated with health. Different commercial tests use different formulas and reference panels, and many of the exact calculations are proprietary.

Because this is a composite metric of an entire bacterial community rather than a single molecule, it is sensitive to many influences: diet in the days before testing, recent medications, illness, and even how the sample was collected and stored. That sensitivity is part of why a single number is best read as a snapshot of one moment, not a fixed trait of your biology.

Inflammatory Bowel Disease

Dysbiosis indexes built from stool microbiome data consistently differ between people with inflammatory bowel disease (IBD) and healthy controls. In a study of pediatric IBD patients, a microbial dysbiosis index was associated with the severity and clinical activity of the disease, and the authors proposed it as a tool for diagnosis and prognosis. In a 296-person cohort with adult IBD, dysbiosis combined with stool features predicted response to biologic therapy with 73.9% accuracy. Microbiome-based panels for IBD have also outperformed fecal calprotectin (a routine stool inflammation marker) in distinguishing IBD from controls in larger validation work.

What this means for you: if you already carry an IBD diagnosis or are being worked up for one, a dysbiosis score adds a different kind of information than inflammation labs alone. It reflects who is living in your gut, not just how angry your gut wall looks.

Irritable Bowel Syndrome

A meta-analysis of case-control studies in IBS found consistent shifts in gut bacteria, including lower fecal Lactobacillus and Bifidobacterium and higher Escherichia coli, regardless of IBS subtype or geography. In commercial dysbiosis testing, microbiome imbalance has been detected in roughly 70 to 80 percent of people with IBS or IBD compared with about 16 percent of healthy individuals.

If you have ongoing bloating, urgency, or abdominal pain that has not been explained by structural disease, a dysbiosis score can help frame whether your microbiome looks more like that of someone with functional gut disease, which can guide decisions around diet and therapy.

Beyond the Gut: Systemic Associations

Dysbiosis-type indexes have been linked to disease in the rest of the body, though the evidence is observational and the mechanisms are still being mapped. In a cirrhosis cohort, severe gut dysbiosis was an independent risk factor for death. A meta-analysis of 92 observational studies found dysbiosis patterns in rheumatic diseases. Gut microbiota composition was significantly altered in COVID-19 patients and reflected disease severity. After successful Helicobacter pylori eradication, a gastric microbial dysbiosis index decreased and gastric microbiota looked more like that of uninfected people.

These associations are correlations, not proof that the gut microbiome causes each disease. They do suggest that dysbiosis is a useful systemic signal worth tracking, particularly if you carry risk factors for any of these conditions.

When Results Can Be Misleading

Gut bacteria respond to short-term inputs, so several common factors can push your score in either direction without reflecting any lasting change in your gut health.

• Recent antibiotics: even short courses cause measurable reductions in gut microbiome diversity. A meta-analysis in children confirmed reduced diversity and richness after antibiotic exposure. Wait at least four to six weeks after a course before testing if you want a representative reading.
• Acute exercise or illness: in an exercise study of myalgic encephalomyelitis/chronic fatigue syndrome (a debilitating fatigue condition), a single maximal exercise bout shifted stool microbiota over 15 minutes to 72 hours. Avoid testing within a few days of an unusually intense workout, gastrointestinal infection, or hospitalization.
• Recent diet swings: stool microbiome profiles vary day to day with diet. Daily quantitative profiling found substantial temporal variation in most gut microbial genera, with diet and stool moisture as significant influences. Aim to test during a typical week, not during a major dietary change.
• Drug confounders: proton pump inhibitors (acid-blocking drugs like omeprazole), commonly used over-the-counter and by prescription, are associated with a less healthy gut microbiome. NSAIDs (anti-inflammatory drugs like ibuprofen), opioids, antipsychotics, antidepressants, and laxatives all show measurable microbiome effects. The reading reflects your gut while on the medication, which may not represent your underlying baseline.

Tracking Your Trend

Because gut bacteria fluctuate with diet, sleep, travel, and medications, a single dysbiosis score is best understood as one frame in a movie. Daily quantitative profiling of healthy adults found substantial temporal variation across most gut microbial genera. The pattern over months tells you far more than any single number, particularly if you are using diet, fiber, or other interventions to try to reshape your gut.

Get a baseline when your routine is stable, retest after about three months if you are making sustained changes, and track at least annually after that. If your score moves into a worse range and stays there across two consecutive tests, that is a stronger signal than a single high reading taken on a stressful or atypical week.

What to Do With an Abnormal Result

An elevated dysbiosis score on its own does not diagnose a disease. It does justify a closer look at the rest of your gut picture. Pair it with other stool markers from the same panel: calprotectin and eosinophil protein X reflect gut inflammation, pancreatic elastase 1 reflects digestive enzyme output, and secretory IgA reflects gut immune activity. A noninvasive microbiome-based test for IBD has shown higher diagnostic performance than fecal calprotectin alone, suggesting that combining microbiome data with inflammation markers gives a more complete picture than either one alone.

If your score is elevated and you have ongoing gut symptoms, blood in stool, unintended weight loss, or a family history of IBD or colorectal cancer, this is a reason to involve a gastroenterologist rather than self-manage. A high score in an asymptomatic person with normal companion markers is more often a prompt to look at diet, fiber, recent medications, and life stress, then retest.